Anbio Biotechnology (NASDAQ:NNNN) Sees Large Volume Increase – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN) shares saw unusually-high trading volume on Monday . Approximately 88,688 shares were traded during mid-day trading, an increase of 17% from the previous session’s volume of 75,852 shares.The stock last traded at $5.4650 and had previously closed at $5.25.

Analyst Ratings Changes

Separately, Weiss Ratings lowered Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Anbio Biotechnology Trading Up 4.4%

The firm has a fifty day simple moving average of $8.43 and a 200-day simple moving average of $18.03.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.